Meeting Brochure and registration form      SMDM Homepage

Tuesday, October 23, 2007 - 4:00 PM
H-1

THE IMPACT OF PATIENT PARTICIPATION ON ADHERENCE AND CLINICAL OUTCOME IN PRIMARY CARE OF DEPRESSION

Daniela Simon, Dipl.Psych., Freiburg, Germany, Andreas Loh, PhD, University Medical Center, Freiburg, Germany, Rainer Leonhart, PhD, University of Freiburg Institute for Psychology, Freiburg, Germany, Celia Wills, PhD, RN, Michigan State University, East Lansing, MI, and Martin Härter, MD, PhD, University Medical Center, Freiburg, Germany.

Purpose: Patient participation in shared treatment decision making is hypothesized to improve depression treatment adherence and clinical outcomes in depressed patients. The aim of this study was to evaluate the impact of patient participation on these factors via structural equation modeling.

Methods: A survey was conducted with 30 general practitioners and 207 depressed patients, at initial consultation and six to eight weeks later. General practitioners documented their clinical practice and patients completed questionnaires including Brief-PHQ for depression and clinical outcome, patient participation (scale by Man-Son-Hing) and visual analogue scales for treatment adherence.

Results: Correlation analysis showed significant correlations between patient participation and adherence (patient rating r=.36, physician rating r=.21, p<.05) and between patient participation and clinical outcome was attributable to patient adherence (beta=.41) and baseline depression severity (beta=.65). Depression severity predicted clinical outcome but not patient participation. Participation predicted adherence but did not directly affect clinical outcome. Adherence was explainable by physician (beta = .57) and patient reported treatment adherence (beta =.66)

Conclusion: In a specific pathway via adherence improving patient participation in decision making can foster improved clinical outcomes. The research findings reveal the significance of patient participation as key factor to address for improving treatment adherence and clinical outcome. Quality improvement strategies for depression treatment should emphasize patient participation.